Metaiodobenzylguanidine imaging comes of age: A new arrow in the prognostic quiver for heart failure patients Journal Article


Authors: Strauss, H. W.; Johnson, M. N.; Schoder, H.; Tamaki, N.
Article Title: Metaiodobenzylguanidine imaging comes of age: A new arrow in the prognostic quiver for heart failure patients
Keywords: clinical trial; disease course; nonhuman; outcome assessment; radiopharmaceuticals; image analysis; analytic method; editorial; high risk patient; drug uptake; isotope labeling; iodine radioisotopes; heart death; heart failure; (3 iodobenzyl)guanidine; (3 iodobenzyl)guanidine i 123; 3-iodobenzylguanidine; drug clearance; collimator; heart arrhythmia; mediastinum; heart; radionuclide imaging; concentration response; heart muscle; myocardium; cardiomyopathy; noradrenalin; guanethidine; meta-iodobenzylguanidine; sympathetic nervous system; cardiovascular parameters; heart function test; heart to mediastinum uptake ratio; new york heart association functional class i; new york heart association functional class ii
Journal Title: Journal of the American College of Cardiology
Volume: 55
Issue: 20
ISSN: 0735-1097
Publisher: Elsevier Science, Inc.  
Date Published: 2010-05-18
Start Page: 2222
End Page: 2224
Language: English
DOI: 10.1016/j.jacc.2010.02.023
PUBMED: 20466202
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 20 April 2011" - "CODEN: JACCD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michelle Nadine Johnson
    14 Johnson
  2. Heiko Schoder
    546 Schoder
  3. Harry W Strauss
    166 Strauss